Innovating.works Conecta tu I+D

Showing 1 to 20 of 21 results

WILSON: Distributed data modelling and Federated Digital Twinning for lifecycle data driven sustainable oper... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un HORIZON EUROPE: HORIZON-CL5-2023-D4-02 As the built environment continues to face challenges such as climate change, energy consumption, and social inequality, there is a growing...
2024-04-17 - 2028-04-30 | Financiado

LIVERATION: Unravelling the impact of Radiofrequency in liver surgery the key to decrease local recurrence? CONSORCIO MAR PARC DE SALUT DE BARCELONA tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 Colorectal cancer (CRC) ranks fourth in cancer deaths worldwide. Between 20% and 30% of patients with advanced CRC have liver metastases (CR...
2023-05-08 - 2028-05-31 | Financiado

Sagittarius: A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE S... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 SAGITTARIUS aim to optimize the clinical management of locoregional stage II high-risk/stage III colon cancer (LRCC). Approximately half of...
2023-04-27 - 2028-06-30 | Financiado

ICOD: Improving COgnition in Down syndrome CONSORCIO MAR PARC DE SALUT DE BARCELONA tramitó un H2020: H2020-SC1-BHC-2018-2020 Cognitive disabilities in individuals with Down syndrome (DS), also known as Trisomy 21, have no approved pharmacological treatment and repr...
2021-01-21 - 2026-01-31 | Financiado

STOPSTORM: A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE ENTRANT TACHYCARDIA CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-SC1-BHC-2018-2020 Ventricular tachycardia (VT) is an unpredictable and potentially deadly condition and should be promptly treated with catheter ablation and...
2021-01-21 - 2027-04-30 | Financiado

SISAQOL-IMI: Establishing international standards in the analysis of patient reported outcomes and health related... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Measuring and quantifying how a patient feels or functions during treatment is an important endpoint in cancer clinical trials. It is genera...
2020-11-09 - 2024-12-31 | Financiado

LiverScreen: Screening for liver fibrosis population based study across European countries CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-SC1-BHC-2018-2020 Liver cirrhosis is a very common and severe chronic disease, responsible for high morbidity, impaired quality of life, major healthcare cost...
2019-12-12 - 2025-06-30 | Financiado

MENTUPP: Mental Health Promotion and Intervention in Occupational Settings MENTUPP CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-SC1-BHC-2018-2020 Depression and anxiety are the most prevalent mental health difficulties in the workplace in the EU, causing immense suffering and costing t...
2019-12-05 - 2023-12-31 | Financiado

AIR-NB: Pre natal exposure to urban AIR pollution and pre and post Natal Brain development CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: ERC-2017-ADG Air pollution is the main urban-related environmental hazard. It appears to affect brain development, although current evidence is inadequat...
2018-08-09 - 2023-12-31 | Financiado

MyPeBS: International Randomized Study Comparing personalized Risk Stratified to Standard Breast Cancer Scr... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-SC1-2016-2017 MyPeBS addresses the crucial and timely question of the future of breast cancer screening in Europe. Indeed current standard mammographic sc...
2017-12-05 - 2026-06-30 | Financiado

R-LiNK: Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I di... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un H2020: H2020-SC1-2016-2017 Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention...
2017-11-21 - 2024-06-30 | Financiado

MedBioinformatics: Creating medically driven integrative bioinformatics applications focused on oncology CNS disorders... CONSORCIO MAR PARC DE SALUT DE BARCELONA tramitó un H2020: H2020-PHC-2014-2015 Progress in biomedical research and healthcare requires profiting from the huge amount of data and knowledge that are generated. However, mo...
2015-04-07 - 2018-04-30 | Financiado

OPEN PHACTS: The Open Pharmacological Concepts Triple Store CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un FP6: Drug discovery is data-hungry and all major pharmaceutical companies maintain extensive in-house instances of public data alongside internal...
2011-03-01 - 2016-02-29 | Financiado

OPEN PHACTS: The Open Pharmacological Concepts Triple Store CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un FP7: Drug discovery is data-hungry and all major pharmaceutical companies maintain extensive in-house instances of public data alongside internal...
Financiado

PAIN-OUT: Improvement in Postoperative PAIN OUTcome CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un FP7: The main objective of the proposed project is to develop and to validate a system for measurement and feedback of outcome quality and suppor...
Financiado

EURODRG: EuroDRG Diagnosis Related Groups in Europe towards Efficiency and Quality CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un FP7: Payment systems are fundamental to any health care system, introducing powerful incentives and fierce technical design complexities. DRG-sys...
Financiado

ASTRO-LAB: ASSESSMENT OF THE SAFETY OF LABAS IN ASTHMA IN ROUTINE CARE BY COMBINING HEALTH CARE DATABASES AND D... CONSORCIO MAR PARC DE SALUT DE BARCELONA participó en un FP7: Background: The efficacy of long-acting β-agonists (LABAs) in asthma has been demonstrated but their safety remains an issue, particularly i...
Financiado

IMIM